All Stories

  1. Global reporting on tuberculosis preventive treatment among contacts

    Article • European Respiratory Journal, January 2022, European Respiratory Society (ERS)

    Dr Dennis Falzon

  2. WHO guidance on multidrug-resistant tuberculosis treatment: using and communicating the evidence

    Article • European Respiratory Journal, March 2020, European Respiratory Society (ERS)

    Dr Dennis Falzon

  3. Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectives

    Article • European Respiratory Journal, November 2017, European Respiratory Society (ERS)

    Dr Dennis Falzon

  4. Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis

    Article • European Respiratory Journal, April 2017, European Respiratory Society (ERS)

    Dr Dennis Falzon

  5. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update

    Article • European Respiratory Journal, March 2017, European Respiratory Society (ERS)

    Dr Dennis Falzon

  6. Investing in a novel shorter treatment regimen for multidrug-resistant tuberculosis: to be repeated

    Article • European Respiratory Journal, March 2017, European Respiratory Society (ERS)

    Dr Dennis Falzon

  7. Digital health for the End TB Strategy: developing priority products and making them work

    Article • European Respiratory Journal, May 2016, European Respiratory Society (ERS)

    Dr Dennis Falzon

  8. Monitoring Therapy Adherence of Tuberculosis Patients by using Video-Enabled Electronic Devices

    Article • Emerging Infectious Diseases, March 2016, Centers for Disease Control and Prevention (CDC)

    Dr Dennis Falzon

  9. Numbers needed to treat to prevent tuberculosis

    Article • European Respiratory Journal, November 2015, European Respiratory Society (ERS)

    Dr Dennis Falzon

  10. Joint WHO/ERS initiative on e-/m-Health for TB and tobacco control

    Article • September 2015, European Respiratory Society (ERS)

    Dr Dennis Falzon

  11. Active pharmacovigilance for multidrug-resistant tuberculosis patients treated with Linezolid, Belarus – 2014-2015

    Article • September 2015, European Respiratory Society (ERS)

    Dr Dennis Falzon

  12. The role of eHealth and mHealth in tuberculosis and tobacco control: a WHO/ERS consultation

    Article • European Respiratory Journal, July 2015, European Respiratory Society (ERS)

    Dr Dennis Falzon

  13. Factors associated with treatment success and death in cases with multidrug-resistant tuberculosis in Bulgaria, 2009–2010

    Article • International Journal of Mycobacteriology, June 2015, Elsevier

    Dr Dennis Falzon

  14. WHO's new End TB Strategy

    Article • The Lancet, May 2015, Elsevier

    Dr Dennis Falzon

  15. Drug resistance and tuberculosis elimination in low-incidence countries: Figure 1–

    Article • European Respiratory Journal, November 2014, European Respiratory Society (ERS)

    Dr Dennis Falzon

  16. Tuberculosis control: hard questions

    Article • The Lancet, November 2014, Elsevier

    Dr Dennis Falzon

  17. Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone

    Article • Bulletin of the World Health Organization, October 2014, WHO Press

    Dr Dennis Falzon

  18. Drug-resistant tuberculosis in the WHO European Region: An analysis of surveillance data

    Article • Drug Resistance Updates, December 2013, Elsevier

    Dr Dennis Falzon

  19. Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data

    Article • The Lancet Infectious Diseases, August 2013, Elsevier

    Dr Dennis Falzon

  20. Global Epidemiology of Tuberculosis

    Article • Seminars in Respiratory and Critical Care Medicine, March 2013, Thieme Publishing Group

    Dr Dennis Falzon

  21. Drug-resistant tuberculosis: latest advances

    Article • The Lancet Respiratory Medicine, March 2013, Elsevier

    Dr Dennis Falzon

  22. Multidrug-Resistant Tuberculosis, Somalia, 2010–2011

    Article • Emerging Infectious Diseases, March 2013, Centers for Disease Control and Prevention (CDC)

    Dr Dennis Falzon

  23. A Systematic Review of Reported Cost for Smear and Culture Tests during Multidrug-Resistant Tuberculosis Treatment

    Article • PLoS ONE, February 2013, PLOS

    Dr Dennis Falzon

  24. Multidrug-resistant tuberculosis in children: evidence from global surveillance

    Article • European Respiratory Journal, December 2012, European Respiratory Society (ERS)

    Dr Dennis Falzon

  25. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF

    Article • European Respiratory Journal, November 2012, European Respiratory Society (ERS)

    Dr Enrico Tortoli, Dr Dennis Falzon

  26. Use of Anti-Retroviral Therapy in Tuberculosis Patients on Second-Line Anti-TB Regimens: A Systematic Review

    Article • PLoS ONE, November 2012, PLOS

    Dr Dennis Falzon

  27. WHO guidance on electronic systems to manage data for tuberculosis care and control

    Article • Journal of the American Medical Informatics Association, November 2012, Oxford University Press (OUP)

    Dr Dennis Falzon

  28. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

    Article • European Respiratory Journal, October 2012, European Respiratory Society (ERS)

    Dr Dennis Falzon, Professor JEROME ROBERT

  29. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects

    Article • Tuberculosis, September 2012, Elsevier

    Dr Dennis Falzon

  30. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010

    Article • Bulletin of the World Health Organization, November 2011, WHO Press

    Dr Dennis Falzon

  31. Antituberculosis therapy and current global guidelines

    Article • October 2011, Future Medicine

    Dr Dennis Falzon

  32. Giving a voice to those who die young: the fatal impact of tuberculosis and HIV in South Africa

    Article • Future Microbiology, November 2010, Future Medicine

    Dr Dennis Falzon

  33. Ambulatory-Based Standardized Therapy for Multi-Drug Resistant Tuberculosis: Experience from Nepal, 2005–2006

    Article • PLoS ONE, December 2009, PLOS

    Dr Dennis Falzon

  34. Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance

    Article • The Lancet, May 2009, Elsevier

    Dr Dennis Falzon

  35. Multidrug-resistant Tuberculosis in Central Asia

    Article • Emerging Infectious Diseases, May 2004, Centers for Disease Control and Prevention (CDC)

    Dr Dennis Falzon

  36. Assessment of Dietary Exposure to Some Persistent Organic Pollutants in the Republic of Karakalpakstan of Uzbekistan

    Article • Environmental Health Perspectives, April 2003, Environmental Health Perspectives

    Dr Dennis Falzon

  37. Not a drop to drink in the Aral Sea

    Article • The Lancet, November 2001, Elsevier

    Dr Dennis Falzon

  38. Surveillance for Tuberculosis in Europe

    Article • Wiley

    Dr Dennis Falzon